I mostly agree, Cody. The one difference I see is that, if the peptides show strong results, it should have an effect on the valuation of NGIO and hopefully the SP once it starts trading. That in itself is potentially a game changer (not an incremental push) for the owners of NGIO... GNBT and us.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links